130 related articles for article (PubMed ID: 2923256)
1. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.
Arnauld E; Bibene V; Meynard J; Rodriguez F; Vincent JD
Am J Physiol; 1989 Mar; 256(3 Pt 2):R674-84. PubMed ID: 2923256
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin analgesia: specificity of action and non-opioid effects.
Kordower JH; Bodnar RJ
Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
[TBL] [Abstract][Full Text] [Related]
3. Central injections of arginine vasopressin prolong extinction of active avoidance.
Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
[TBL] [Abstract][Full Text] [Related]
4. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
5. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
de Wied D; Elands J; Kovács G
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
Lebrun C; Le Moal M; Koob GF; Bloom FE
Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
[TBL] [Abstract][Full Text] [Related]
7. Mediation of the stress-induced prolactin release by hypothalamic histaminergic neurons and the possible involvement of vasopressin in this response.
Kjaer A; Knigge U; Olsen L; Vilhardt H; Warberg J
Endocrinology; 1991 Jan; 128(1):103-10. PubMed ID: 1986913
[TBL] [Abstract][Full Text] [Related]
8. Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate behavioral effects of interleukin-1 in rat.
Bluthé RM; Dantzer R
Brain Res Bull; 1992 Dec; 29(6):897-900. PubMed ID: 1473021
[TBL] [Abstract][Full Text] [Related]
9. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.
Koob GF; Le Moal M; Gaffori O; Manning M; Sawyer WH; Rivier J; Bloom FE
Regul Pept; 1981 Jun; 2(3):153-63. PubMed ID: 7255768
[TBL] [Abstract][Full Text] [Related]
10. Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep-wake rhythm in the rat.
Kruisbrink J; Mirmiran M; Van der Woude TP; Boer GJ
Brain Res; 1987 Sep; 419(1-2):76-86. PubMed ID: 3676743
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular infusion but not bolus injection of vasopressin increases the cerebrospinal fluid pressure in awake rabbits.
Sørensen PS; Gyring JA
Neurol Res; 1990 Jun; 12(2):83-8. PubMed ID: 1974706
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
Diamant M; De Wied D
Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin enhances the clearance of beta-endorphin immunoreactivity from rat cerebrospinal fluid.
Sweep CG; Boomkamp MD; Barna I; Logtenberg AW; Wiegant VM
Acta Endocrinol (Copenh); 1990 Feb; 122(2):191-200. PubMed ID: 2138399
[TBL] [Abstract][Full Text] [Related]
14. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation.
Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K
Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats.
Seckl JR; Lightman SL
Brain Res; 1987 Oct; 423(1-2):279-85. PubMed ID: 3676810
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
Federico P; Veale WL; Pittman QJ
Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
Bodnar RJ; Truesdell LS; Nilaver G
Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
[TBL] [Abstract][Full Text] [Related]
18. Role of endogenous vasopressin in development of gastric ulcer induced by restraint and water immersion.
Honda K; Fukuda S; Ishikawa SE; Kuzuya T; Saito T
Am J Physiol; 1994 May; 266(5 Pt 2):R1448-53. PubMed ID: 8203619
[TBL] [Abstract][Full Text] [Related]
19. Septal arginine vasopressin (AVP) receptor regulation in rats depleted of septal AVP following long-term castration.
Poulin P; Pittman QJ
J Neurosci; 1991 Jun; 11(6):1531-9. PubMed ID: 2045876
[TBL] [Abstract][Full Text] [Related]
20. Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate social recognition in rat.
Bluthé RM; Dantzer R
Brain Res; 1992 Feb; 572(1-2):261-4. PubMed ID: 1611520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
